Ryuichi Moriya

695 total citations
14 papers, 542 citations indexed

About

Ryuichi Moriya is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Nutrition and Dietetics. According to data from OpenAlex, Ryuichi Moriya has authored 14 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 9 papers in Endocrine and Autonomic Systems and 6 papers in Nutrition and Dietetics. Recurrent topics in Ryuichi Moriya's work include Regulation of Appetite and Obesity (9 papers), Neuropeptides and Animal Physiology (8 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Ryuichi Moriya is often cited by papers focused on Regulation of Appetite and Obesity (9 papers), Neuropeptides and Animal Physiology (8 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Ryuichi Moriya collaborates with scholars based in Japan and United States. Ryuichi Moriya's co-authors include Satoshi Mashiko, Junko Itô, Takashi Shirakura, Akio Kanatani, Toru Seo, Hisashi Iwaasa, Akane Ishihara, Yasuyuki Nomura, Takashi Uehara and Masao Matsuda and has published in prestigious journals such as FEBS Letters, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Ryuichi Moriya

14 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuichi Moriya Japan 12 245 173 153 131 117 14 542
Martina Holubová Czechia 14 172 0.7× 221 1.3× 163 1.1× 79 0.6× 226 1.9× 23 538
Satoshi Hirako Japan 13 171 0.7× 114 0.7× 80 0.5× 90 0.7× 138 1.2× 35 436
D. Rapetti Italy 13 460 1.9× 99 0.6× 81 0.5× 312 2.4× 301 2.6× 15 679
Makoto Ito Japan 16 424 1.7× 224 1.3× 54 0.4× 266 2.0× 224 1.9× 19 747
David S. Roane United States 15 101 0.4× 101 0.6× 148 1.0× 65 0.5× 140 1.2× 24 469
Ilaria Bulgarelli Italy 14 384 1.6× 113 0.7× 89 0.6× 241 1.8× 257 2.2× 22 654
Dong‐Yih Kuo Taiwan 16 438 1.8× 158 0.9× 188 1.2× 268 2.0× 199 1.7× 44 723
R. Puech France 16 150 0.6× 278 1.6× 375 2.5× 66 0.5× 101 0.9× 33 782
Kyoko Miyasaka Japan 12 144 0.6× 131 0.8× 259 1.7× 78 0.6× 106 0.9× 28 519
Drew T. Weingarth United States 8 825 3.4× 117 0.7× 120 0.8× 536 4.1× 561 4.8× 8 1.1k

Countries citing papers authored by Ryuichi Moriya

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Moriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Moriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Moriya more than expected).

Fields of papers citing papers by Ryuichi Moriya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Moriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Moriya. The network helps show where Ryuichi Moriya may publish in the future.

Co-authorship network of co-authors of Ryuichi Moriya

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Moriya. A scholar is included among the top collaborators of Ryuichi Moriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Moriya. Ryuichi Moriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sato, Masahito, Satoshi Takeuchi, Ryuichi Moriya, et al.. (2020). Novel TLR2xTLR4 Bispecific Antibody Inhibits Bacterial Sepsis. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(1). 6–10. 3 indexed citations
2.
Moriya, Ryuichi, Satoshi Mashiko, Akane Ishihara, et al.. (2009). Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice. Peptides. 30(7). 1318–1322. 15 indexed citations
3.
Mashiko, Satoshi, Ryuichi Moriya, Akane Ishihara, et al.. (2009). Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. European Journal of Pharmacology. 615(1-3). 113–117. 39 indexed citations
4.
Moriya, Ryuichi, Toru Fujikawa, Junko Itô, et al.. (2009). Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice. European Journal of Pharmacology. 627(1-3). 258–264. 19 indexed citations
5.
Moriya, Minoru, Shunji Sakuraba, Toshihiro Sakamoto, et al.. (2009). Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3568–3572. 6 indexed citations
6.
Moriya, Ryuichi, Takashi Shirakura, Hiroyasu Hirose, et al.. (2009). NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 31(4). 671–675. 24 indexed citations
7.
Moriya, Minoru, Shunji Sakuraba, Toshihiro Sakamoto, et al.. (2009). Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4589–4593. 14 indexed citations
8.
Moriya, Ryuichi, Takashi Shirakura, Junko Itô, Satoshi Mashiko, & Toru Seo. (2009). Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. American Journal of Physiology-Endocrinology and Metabolism. 297(6). E1358–E1365. 135 indexed citations
10.
Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2008). Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine. Obesity. 16(7). 1510–1515. 24 indexed citations
11.
Moriya, Ryuichi, Hideki Sano, Tatsuya Umeda, et al.. (2006). RFamide Peptide QRFP43 Causes Obesity with Hyperphagia and Reduced Thermogenesis in Mice. Endocrinology. 147(6). 2916–2922. 83 indexed citations
12.
Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2006). A Pair-Feeding Study Reveals That a Y5 Antagonist Causes Weight Loss in Diet-Induced Obese Mice by Modulating Food Intake and Energy Expenditure. Molecular Pharmacology. 71(2). 602–608. 37 indexed citations
13.
Mashiko, Satoshi, Akane Ishihara, Akira Gomori, et al.. (2005). Antiobesity Effect of a Melanin-Concentrating Hormone 1 Receptor Antagonist in Diet-Induced Obese Mice. Endocrinology. 146(7). 3080–3086. 58 indexed citations
14.
Moriya, Ryuichi, Takashi Uehara, & Yasuyuki Nomura. (2000). Mechanism of nitric oxide‐induced apoptosis in human neuroblastoma SH‐SY5Y cells. FEBS Letters. 484(3). 253–260. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026